ResMed | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Ansell USD 104.45M 115.95M 2024-06
AtriCure USD 72.18M 1.05M 2024-12
Baxter International USD 615M 16M 2024-12
Cochlear AUD 465.6M 33.6M 2024-06
Cooper Companies USD 387.9M 3.5M 2025-01
CSL USD 1.38B 341M 2024-06
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 491.9M 70.5M 2024-12
Fisher Paykel Healthcare NZD 260.5M 4.3M 2024-09
Globus Medical USD 253.48M 12.74M 2024-12
Haemonetics USD 105.72M 686K 2024-12
Hologic USD 265M 15.8M 2024-12
Idexx Laboratories USD 251.24M 13.08M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 612.6M 102M 2024-12
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Philips EUR 1.33B 99M 2024-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 241.61M 2.63M 2024-12
Sigma Healthcare AUD 140.17M 5.4M 2024-07
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Steris USD 335.45M 9.36M 2024-12
Teleflex USD 254.55M 7.3M 2024-12
Thermo Fisher Scientific USD 2.21B 114M 2024-12



ResMed Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.